3 days ago
CORT
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Top 12%
#586 out of 5278 analysts
Average Return
+13.53%
Win Rate
58%53 out of 92
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +164.51% | $35.16 | $93.00 | 2023-10-16 - 2024-10-16 | Strong Buy |
Avadel Pharmaceuticals PLCAVDL | +137.72% | $7.82 | $18.59 | 2025-01-12 - 2025-10-28 | Strong Buy |
Axsome Therapeutics IncAXSM | +120.53% | $103.26 | $227.72 | 2025-08-05 - 2026-05-15 | Strong Buy |
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-02 - 2024-01-24 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +107.07% | $16.56 | $34.29 | 2025-06-25 - 2026-05-15 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
10 days ago
ALKS
16 days ago
TEVA
25 days ago
RPRX
a month ago
AXSM
4 months ago
AXSM
6 months ago
JAZZ
6 months ago
ABBV
7 months ago
NBIX
8 months ago
TEVA
2 years ago
TEVA
2 years ago
LEGN
2 years ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Corcept Therapeutics IncCORT | 2 | Strong Buy | $72.00 | +27.73% | Upgrades | 3 days ago |
Alkermes PLCALKS | 5 | Strong Buy | $48.00 | +28.07% | Maintains | 10 days ago |
Teva Pharmaceutical Industries LtdTEVA | 11 | Strong Buy | $42.00 | +22.48% | Maintains | 16 days ago |
Royalty Pharma PLCRPRX | 5 | Strong Buy | $57.00 | +7.85% | Maintains | 25 days ago |
Amneal Pharmaceuticals IncAMRX | 1 | Strong Buy | $19.00 | +59.26% | Initiates Coverage On | a month ago |
Axsome Therapeutics IncAXSM | 8 | Strong Buy | $259.00 | +13.74% | Maintains | a month ago |
Incyte CorpINCY | 3 | Hold | $94.00 | -1.37% | Maintains | 2 months ago |
AlvotechALVO | 2 | Strong Buy | $6.00 | +81.27% | Maintains | 2 months ago |
Cytokinetics IncCYTK | 6 | Hold | $69.00 | -9.03% | Maintains | 2 months ago |
United Therapeutics CorpUTHR | 12 | Strong Buy | $705.00 | +23.99% | Maintains | 2 months ago |
Harmony Biosciences Holdings IncHRMY | 4 | Hold | $46.00 | +52.87% | Downgrades | 3 months ago |
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $178.00 | +12.36% | Maintains | 4 months ago |
Insmed IncINSM | 1 | Strong Buy | $215.00 | +96.99% | Maintains | 4 months ago |
Acadia Pharmaceuticals IncACAD | 9 | Strong Buy | $40.00 | +86.92% | Maintains | 4 months ago |
Legend Biotech CorpLEGN | 4 | Strong Buy | $48.00 | +74.23% | Maintains | 5 months ago |
Biohaven LtdBHVN | 5 | Hold | $11.00 | +25.57% | Downgrades | 6 months ago |
Jazz Pharmaceuticals PLCJAZZ | 7 | Hold | $188.00 | -17.82% | Downgrades | 6 months ago |
Abbvie IncABBV | 1 | Hold | $220.00 | +4.57% | Maintains | 6 months ago |
Exelixis IncEXEL | 5 | Hold | $40.00 | -20.21% | Maintains | 6 months ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Hold | $20.00 | -7.58% | Downgrades | 7 months ago |
Immunovant IncIMVT | 1 | Hold | $18.00 | -34.52% | Maintains | 10 months ago |
Coherus Oncology IncCHRS | 5 | Hold | $1.05 | N/A | Maintains | a year ago |
Arcellx IncACLX | 2 | Strong Buy | $114.00 | N/A | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $79.00 | N/A | Maintains | 2 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | 3 years ago |
Viatris IncVTRS | 2 | Hold | $12.00 | N/A | Upgrades | 4 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.